The targeting construct inserted into the locus contained a CAG promoter that drives ubiquitous expression of the human cDNA with nucleotide substitutions that result in the amino acid substitution of threonine for alanine at position 230 (A230T) preceded by a floxed STOP cassette and followed by an IRES and the truncated human CD2 tag.